VANCOUVER, BC, Dec. 14, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research for psychedelics, announces the appointment of Doron Sagman, MD, FRCPC, as the Company’s new Chief Medical Officer (“CMO”). Dr. Joel Raskin who was acting CMO will transition into an advisory role for MINDCURE.

Source

Previous articleatai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
Next articlePT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative Financing Vine